OUR PRODUCTS

MOBILE APPS

GENERAL INFO

EDIT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Editas Medicine (EDIT) Earnings Date & Reports

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EDIT is expected to report earnings to fall 46.84% to -33 cents per share on November 10

Editas Medicine EDIT Stock Earnings Reports

Q3'25

Est.

$-0.33

Q2'25

Missed

by $0.23

Q1'25

Missed

by $0.36

Q4'24

Missed

by $0.22

Q3'24

Est.

$-0.75

The last earnings report on August 12 showed earnings per share of -62 cents, missing the estimate of -40 cents. With 3.20M shares outstanding, the current market capitalization sits at 272.46M.

View a ticker or compare two or three

Compare

EDIT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EDIT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EDIT showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

11 Hurley Street

Phone

+1 617 401-9000

Employees

265

Web

https://www.editasmedicine.com